pv701
Biologicalexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2003 (NCT00055705)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Oncolytic virusOTHER
Oncolytic virus other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pv701
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00081211 | Phase 1 | Apr 1, 2004 | National Cancer Institute (NCI), University of Chicago |
| NCT00055705 | Phase 1 | Jan 1, 2003 | Cornell University, National Cancer Institute (NCI) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 2 | 1 | 1 | 2003 |
| Cornell University | Academic/Hospital | 1 | 1 | 1 | 2003 |
| University of Chicago | Academic/Hospital | 1 | 0 | 1 | 2004 |
3 organizations
Page 1 / 1